维普中文期刊产品整合服务
10篇 您的检索式:作者名="Hubner R D"
    题名 作者 年代 出处 被引量
1Codonimproved Cre recombinase(i Cre)expression in the mouse显示文摘SHIMSHEK D R KIM J HUBNER M R 2002Genesis2002,32,1:1
2Codon - improved Cre recombinase (iCre) expression in the mouse 显示文摘SHIMSHEK D R KIM J HUBNER M R 2002Genesis2002,32,1:1
3In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat显示文摘Hubner R A Kubota E Casler D J 2001J Hypertens2001,19,5:1
4Role of H3K27 demethylasts JMJD3 and UTX in transcriptional regulation显示文摘HUBNER M R SPECTOR D L 2011Cold Spring Harb Symp Quant Biol2011,75,:1
5Endocytosis in maize root cap cells: evidence obtained using heave metal salt solutions显示文摘Hubner R Depta H Robison D G 1985Protoplasma1985,129,:1
6Effect of nitrogen content on the degradation mechanisms of thin Ta-Si-N diffusion barriers for Cu metallization显示文摘HUBNER R HECKER M MATTERN N HOFFMANN V WETZIG K HEUER H WENZEL C ENGELMANN H J GEHRE D ZSCHECH E 2006Thin Solid Films2006,500,12:1
7Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: ameta-analysis of published studies and recommendations显示文摘Richard A Hubner R D Riley L J 2011PLOS ONE2011,10,25:1
8In vitro and in vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat 显示文摘Hubner R A Kubota E Casler D J 2001J Hypertension2001,19,5:1
9In vitro and in vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat 显示文摘Hubner R A Kubota E Casler D J 2001J Hypertens2001,19,5:1
10Health-related quality of life, anxiety, depression and impulsivity in patients with advanced gastroenteropancreatic neuroendocrine tumours显示文摘AIM To compare health-related quality of life(HRQoL),anxiety, depression, and impulsivity scores in patients with and without carcinoid syndrome(CS), and correlated them with serum 5-hydroxyindoleacetic acid(5-HIAA) levels.METHODS Patients with advanced gastroenteropancreatic neuroendocrine tumours(GEPNET), with and without CS completed HRQoL QLQ-C30 and QLQ-GI.NET21, Hospital Anxiety and Depression Scale(HADS) and Barratt Impulsivity Scale(BIS) questionnaires. Twosample Wilcoxon test was applied to assess differences in serum 5-HIAA levels, two-sample Mann-Whitney U test for HRQoL and BIS, and proportion test for HADS, between those with and without CS.RESULTS Fifty patients were included; 25 each with and without CS. Median 5-HIAA in patients with and without CS was 367 nmol/L and 86 nmol/L, respectively(P = 0.003). Scores related to endocrine symptoms were significantly higher amongst patients with CS(P = 0.04) and scores for disease-related worries approached significance in the group without CS, but no other statistically-significant differences were reported between patients with and without CS in responses on QLQ-C30 or QLQ-GI.NET21. Fifteen patients(26%) scored ≥ 8/21 on anxiety scale, and 6(12%) scored ≥ 8/21 on depression scale. There was no difference in median 5-HIAA between those scoring < or ≥ 8/21 on anxiety scale(P = 0.53). There were no statistically significant differences between groups in first or second-order factors(BIS) or total sum(P = 0.23).CONCLUSION Excepting endocrine symptoms, there were no significant differences in HRQoL, anxiety, depression or impulsivity between patients with advanced GEPNET, with or without CS. Over one quarter of patients had high anxiety scores, unrelated to peripheral serotonin metabolism.Alexandra R Lewis Xin Wang Laurice Magdalani Paolo D'Arienzo Colsom Bashir Was Mansoor Richard Hubner Juan W Valle Mairéad G McNamara 2018World Journal of Gastroenterology2018,24,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费